Cross Country Healthcare Statistics
Total Valuation
FRA:XXY has a market cap or net worth of EUR 288.28 million. The enterprise value is 204.91 million.
| Market Cap | 288.28M |
| Enterprise Value | 204.91M |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 32.76M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.44% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 5.44% |
| Owned by Institutions (%) | 92.65% |
| Float | 28.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 99.01 |
| PS Ratio | 0.30 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | 7.41 |
| P/OCF Ratio | 6.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.05, with an EV/FCF ratio of 5.26.
| EV / Earnings | -15.34 |
| EV / Sales | 0.21 |
| EV / EBITDA | 10.05 |
| EV / EBIT | 55.05 |
| EV / FCF | 5.26 |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.45 |
| Quick Ratio | 3.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.05 |
| Interest Coverage | 1.92 |
Financial Efficiency
Return on equity (ROE) is -3.76% and return on invested capital (ROIC) is 0.64%.
| Return on Equity (ROE) | -3.76% |
| Return on Assets (ROA) | 0.48% |
| Return on Invested Capital (ROIC) | 0.64% |
| Return on Capital Employed (ROCE) | 0.96% |
| Revenue Per Employee | 100,046 |
| Profits Per Employee | -1,391 |
| Employee Count | 9,605 |
| Asset Turnover | 1.99 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -428,707 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.40% |
| 50-Day Moving Average | 10.51 |
| 200-Day Moving Average | 11.83 |
| Relative Strength Index (RSI) | 33.15 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.77 |
Income Statement
In the last 12 months, FRA:XXY had revenue of EUR 960.94 million and -13.36 million in losses. Loss per share was -0.42.
| Revenue | 960.94M |
| Gross Profit | 193.97M |
| Operating Income | 3.69M |
| Pretax Income | -13.79M |
| Net Income | -13.36M |
| EBITDA | 17.84M |
| EBIT | 3.69M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 84.49 million in cash and 1.88 million in debt, giving a net cash position of 82.61 million.
| Cash & Cash Equivalents | 84.49M |
| Total Debt | 1.88M |
| Net Cash | 82.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 347.86M |
| Book Value Per Share | 10.70 |
| Working Capital | 178.62M |
Cash Flow
In the last 12 months, operating cash flow was 46.23 million and capital expenditures -7.31 million, giving a free cash flow of 38.93 million.
| Operating Cash Flow | 46.23M |
| Capital Expenditures | -7.31M |
| Free Cash Flow | 38.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 20.19%, with operating and profit margins of 0.38% and -1.39%.
| Gross Margin | 20.19% |
| Operating Margin | 0.38% |
| Pretax Margin | -1.43% |
| Profit Margin | -1.39% |
| EBITDA Margin | 1.86% |
| EBIT Margin | 0.38% |
| FCF Margin | 4.05% |
Dividends & Yields
FRA:XXY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.44% |
| Shareholder Yield | 4.44% |
| Earnings Yield | -4.63% |
| FCF Yield | 13.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:XXY has an Altman Z-Score of 5.3 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.3 |
| Piotroski F-Score | 4 |